10-Q Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001759655-21-000040`
Period End Date	20210930
Filing Date	20211108
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	prva-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 76 Cash Flow Statement 74 Stockholders Equity 35

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$362.11M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	106.23M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	95.99M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$84.63M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$98.38M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$99.12M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	106.23M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	95.99M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.93M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$190.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$469.42M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.81M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.38M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.50M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.98M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$25.37M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$4.95M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.47M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.38M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$162.64M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$138.88M	USD	Point-in-time
Total assets	`Assets`	$632.06M	USD	Point-in-time
Total assets	`Assets`	$328.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.24M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.18M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.30M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$106.81M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$145.00M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.20M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$4.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$187.24M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$146.94M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$31.66M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$32.78M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$333.00K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$39.82M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$38.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$185.32M	USD	Point-in-time
Total liabilities	`Liabilities`	$227.07M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 150,000,000 shares authorized; 106,234,792 and 95,985,817 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$1.06M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 150,000,000 shares authorized; 106,234,792 and 95,985,817 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$960.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$165.67M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$605.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-196.13M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$146.75M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$410.60M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-5.61M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-3.10M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$135.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$632.06M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$328.97M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$690.89M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$251.52M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$207.17M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$603.38M	USD	3 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$467.06M	USD	3 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$160.43M	USD	1 Quarter
Physician and practice expense	`PhysicianAndPracticeExpense`	$521.11M	USD	3 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$190.06M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$131.01M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$77.13M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$25.24M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$35.31M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$7.38M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$4.59M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$18.95M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$2.71M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.79M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$29.20M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$33.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$216.56M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$466.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$457.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.39M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$582.16M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$888.98M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$198.63M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$264.33M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$-12.81M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$21.22M	USD	3 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$8.54M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$-198.09M	USD	3 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-885.00K	USD	3 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-504.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-292.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-1.48M	USD	3 Qtrs
(Loss) income before benefit from income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.10M	USD	1 Quarter
(Loss) income before benefit from income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-198.97M	USD	3 Qtrs
(Loss) income before benefit from income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.04M	USD	1 Quarter
(Loss) income before benefit from income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$19.74M	USD	3 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-8.56M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-2.21M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-7.39M	USD	3 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-20.21M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$5.62M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$16.60M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.33M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$27.12M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-10.89M	USD	1 Quarter
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.78M	USD	1 Quarter
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-85.00K	USD	1 Quarter
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-255.00K	USD	3 Qtrs
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.51M	USD	3 Qtrs
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$27.38M	USD	3 Qtrs
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$16.68M	USD	1 Quarter
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-9.12M	USD	1 Quarter
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-176.25M	USD	3 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.29	USD	3 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.17	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.74	USD	3 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.74	USD	3 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.29	USD	3 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.17	USD	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.90M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.58M	shares	3 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.95M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.95M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.90M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.95M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.58M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.95M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$5.62M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$16.60M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.33M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$27.12M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-10.89M	USD	1 Quarter
Depreciation	`Depreciation`	$895.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$869.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$482.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$483.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$100.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$120.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$228.46M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$363.00K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-7.77M	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-20.42M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$10.14M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-734.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.57M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$7.97M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-2.24M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.09M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.46M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.06M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.06M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$118.00K	USD	3 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$30.88M	USD	3 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$38.19M	USD	3 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$815.00K	USD	3 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$1.77M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$10.03M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$404.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.26M	USD	3 Qtrs
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$67.38M	USD	3 Qtrs
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$42.23M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$380.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$396.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-396.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-380.00K	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	3 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.69M	USD	3 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$656.00K	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$656.00K	USD	3 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$108.00K	USD	3 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$648.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$490.00K	USD	3 Qtrs
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	$10.00M	USD	3 Qtrs
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	-	USD	3 Qtrs
Line of credit payments	`RepaymentsOfLinesOfCredit`	$10.00M	USD	3 Qtrs
Line of credit payments	`RepaymentsOfLinesOfCredit`	-	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-548.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$210.50M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$277.48M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$41.30M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$362.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.19M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$362.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.19M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$1.60M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$855.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$451.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$371.00K	USD	3 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$135.05M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$33.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	328,323.00	shares	3 Qtrs
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExercised`	$108.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueStockOptionsExercised`	$615.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$202.56M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$25.80M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$101.00K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.62M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$16.60M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.33M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$27.12M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-10.89M	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$135.05M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.